Medifast Inc (MED) Company Profile & Statistics

Medifast Inc
MED
(NYSE)
Open
19.22
-0.66 (-3.32%)
in:usd•As of: Nov 08, 2024 15:31 UTC -5
Open
19.73
High
19.73
Low
18.84

About Medifast Inc

CEO

Daniel R. Chard

Headquarters

100 international drive

baltimore, md 21202, united states

Auditor

RSM US LLP

Employees

634

Share Holders

Website

www.medifastinc.com

Industry

miscellaneous commercial services

Sector

commercial services

Company Overview

Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and programs. The company produces, distributes and sells weight loss, weight management and healthy living products throughits direct online channels as well as franchise weight control centers. The company boasts a diversified portfolio of consumable product options, which include bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes and soups. The company sells different types of products, which are formed on the basis of its proprietary formulas across the United States and the Asia-Pacific. The products are sold under brands such as the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life and Flavors of Home. OPTAVIA product line is sold through its community of independent coaches who offer support and guidance to their clients.

Medifast Inc Statistics

Valuation Measures

Market Capitalization ²	210.27M
Enterprise Value	102.25M
Enterprise Value/EBITDA (ttm)	2.18
Price to Earnings Ratio (ttm)	6.52
Price to Book (mrq)	1.04
Price to Sales (ttm)	0.32
Price to Cash (ytd)	1.82

Profitability

Gross Margin (ttm)	73.87%
Operating Margin (ttm)	4.89%
Profit Margin (ttm)	0.97%
Return on Equity (ttm)	15.98%
Return on Invested Capital (ttm)	3.26%
Return on Assets (ttm)	11.01%

Income Statement

Revenue (ttm)	770.18M
Revenue Per Share (ttm)	70.42
Gross Profit (ttm)	569.48M
EBITDA (ttm)³	46.80M
Net Income Avi to Common (ttm)	29.33M
Diluted EPS (ttm)	0.66

Share Statistics

Beta (5Y Monthly)	1.13
52-Week Change	-70.84%
S&P500 52-Week Change	36.91%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	10.94M
Dividend Yield	0.00%
Float ⁴	10.66M
% Held by Insiders	2.50%
% Held by Institutions	95.51%

Balance Sheet

Total Cash (mrq)	163.50M
Total Cash Per Share (mrq)	14.95
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	5.56%
Current Ratio (mrq)	3.11%
Quick Ratio (mrq)	2.46%
Book Value Per Share (mrq)	18.96

Cash Flow

Operating Cash Flow Per Share (ytd)	2.68
Free Cash Flow (ytd)	24.25M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Medifast Inc

Trade With A Regulated Broker